Physician profile
Scott Crowder
NPI 1710084983
$1,923.87
in general payments reported to CMS, 2019-2025
18 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $137 · 2021: $421 · 2022: $401 · 2023: $347 · 2024: $249 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.66 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $454.29 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $298.78 | 2021-2025 | Qelbree |
| Adlon Therapeutics L.P. | $274.33 | 2020-2021 | |
| Axsome Therapeutics, INC. | $250.42 | 2023-2025 | Auvelity |
| Collegium Pharmaceutical, INC. | $146.67 | 2025 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $118.02 | 2022-2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $82.66 | 2021 | |
| Corium, LLC | $80.50 | 2022-2024 | Azstarys |
| E.R. Squibb & Sons, L.L.C. | $48.97 | 2025 | Cobenfy |
| Abbvie INC. | $48.92 | 2023 | Vraylar |
| Sunovion Pharmaceuticals INC. | $31.37 | 2022 | |
| Neos Therapeutics, Lp | $21.06 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.04 | 2022 | |
| Vanda Pharmaceuticals INC. | $19.53 | 2022 | |
| Brainsway USA INC | $15.22 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $12.09 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Crowder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.